BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 16570563)

  • 1. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
    BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
    Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
    Goldstein NS; Thomas M
    Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
    Bayrak R; Yenidünya S; Haltas H
    Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
    Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
    Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.